Archive

Women with heart disease are less likely to receive life-saving drugs than men

Written by | 29 Apr 2024

Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European […]

Equivalency of drug and non-drug therapy for depression in heart failure

Written by | 3 Feb 2024

To treat depression in heart failure, patients can receive with similar efficacy either behavioral activation psychotherapy or antidepressant drug therapy, researchers report. The findings appeared on Jan.17, 2024 […]

Both virtual and in-person nutrition visits help to lower cholesterol, study finds

Written by | 13 Dec 2023

Despite an end to the national public health emergency in May 2023, the use of telehealth remains high, with over 20% of American adults taking appointments online. These visits include […]

Appropriate statin prescriptions increase sixfold with automated referrals

Written by | 22 Nov 2023

The odds of prescribing the appropriate dose of statins—a medicine used to lower “bad” cholesterol levels—increased sixfold when automated referrals were made to pharmacy services, instead of relying […]

Expanding pharmacists’ role for patients with hypertension could prevent 15 million heart attacks and save $1.1 trillion over 30 years, VCU-led study finds

Written by | 7 Nov 2023

If pharmacists had a larger role in prescribing medications to control blood pressure, they could prevent more than 15 million heart attacks, nearly 8 million strokes and more […]

STEP-HFpEF trial – caveats and implications

Written by | 19 Oct 2023

STEP-HFpEF was a randomised, controlled trial designed to find out whether semaglutide for 52 weeks could improve heart failure symptoms and physical function in obese, non-diabetic patients with […]

Semaglutide for prevention or cure of HFpEF?

Written by | 18 Oct 2023

The results of the STEP-HFpEF trial point towards routine use of GLP-1 agonists in heart failure but this has to be balanced against conflicting guidelines and cost pressures […]

How semaglutide impacts HFpEF

Written by | 17 Oct 2023

The results of the STEP-HFpEF trial showed statistically significant benefits “across the board” and these benefits were not due to weight loss alone, according to Vicky Ruszala, Specialist […]

Could semaglutide help obese patients with heart failure?

Written by | 16 Oct 2023

STEP-HFpEF was a randomised, controlled trial designed to find out whether semaglutide for 52 weeks could improve heart failure symptoms and physical function in obese, non-diabetic patients with […]

Commonly prescribed hypertension drug, amlodipine, not actually dangerous

Written by | 14 Oct 2023

A new paper in the journal Function, published by Oxford Univetrsity Press, finds that a widely prescribed drug for treating hypertension, amlodipine, is not dangerous for patients, despite recent concerns from […]

Depressed patients less likely to take their heart medications

Written by | 15 Jul 2023

Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according to research presented today […]

A holistic approach to drug therapy for heart failure

Written by | 8 Jul 2023

A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30 […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.